NasdaqGS - Nasdaq Real Time Price USD

Pacific Biosciences of California, Inc. (PACB)

Compare

1.7200

+0.1500

(+9.55%)

At close: November 19 at 4:00 PM EST

1.7200

0.00

(0.00%)

After hours: 7:22 PM EST

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

173,147.0000

200,521.0000

128,304.0000

130,513.0000

78,893.0000

Cost of Revenue

136,352.0000

147,741.0000

79,269.0000

71,653.0000

46,327.0000

Gross Profit

36,795.0000

52,780.0000

49,035.0000

58,860.0000

32,566.0000

Operating Expense

350,165.0000

363,145.0000

353,854.0000

237,023.0000

136,951.0000

Operating Income

-313,370.0000

-310,365.0000

-304,819.0000

-178,163.0000

-104,385.0000

Net Non Operating Interest Income Expense

-14,226.0000

-14,343.0000

-14,690.0000

-12,530.0000

-267.0000

Other Income Expense

-67,362.0000

6,549.0000

5,261.0000

-84,179.0000

134,055.0000

Pretax Income

-394,958.0000

-318,159.0000

-314,248.0000

-274,872.0000

29,403.0000

Tax Provision

-718.0000

-11,424.0000

-93,649.0000

Net Income Common Stockholders

-394,240.0000

-306,735.0000

-314,248.0000

-181,223.0000

29,403.0000

Diluted NI Available to Com Stockholders

-394,240.0000

-306,735.0000

-314,248.0000

-181,223.0000

29,403.0000

Basic EPS

-1.46

-1.21

-1.40

-0.89

0.18

Diluted EPS

-1.46

-1.21

-1.40

-0.89

0.17

Basic Average Shares

270,540.7500

253,629.0000

224,550.0000

204,136.0000

165,187.0000

Diluted Average Shares

270,540.7500

253,629.0000

224,550.0000

204,136.0000

174,970.0000

Total Operating Income as Reported

-408,833.0000

-334,467.0000

-307,196.0000

-210,435.0000

-104,385.0000

Total Expenses

486,517.0000

510,886.0000

433,123.0000

308,676.0000

183,278.0000

Net Income from Continuing & Discontinued Operation

-394,240.0000

-306,735.0000

-314,248.0000

-181,223.0000

29,403.0000

Normalized Income

-298,950.5436

-281,540.8600

-311,871.0000

-125,603.4800

-102,597.0000

Interest Expense

14,226.0000

14,343.0000

14,690.0000

12,530.0000

267.0000

Net Interest Income

-14,226.0000

-14,343.0000

-14,690.0000

-12,530.0000

-267.0000

EBIT

-380,732.0000

-303,816.0000

-299,558.0000

-262,342.0000

29,670.0000

EBITDA

-326,631.0000

-277,282.0000

-282,240.0000

-250,757.0000

38,974.0000

Reconciled Cost of Revenue

101,044.0000

127,364.0000

61,951.0000

60,068.0000

46,327.0000

Reconciled Depreciation

54,101.0000

26,534.0000

17,318.0000

11,585.0000

9,304.0000

Net Income from Continuing Operation Net Minority Interest

-394,240.0000

-306,735.0000

-314,248.0000

-181,223.0000

29,403.0000

Total Unusual Items Excluding Goodwill

-95,463.0000

-26,135.0000

-2,377.0000

-84,272.0000

132,000.0000

Total Unusual Items

-95,463.0000

-26,135.0000

-2,377.0000

-84,272.0000

132,000.0000

Normalized EBITDA

-231,168.0000

-251,147.0000

-279,863.0000

-166,485.0000

-93,026.0000

Tax Rate for Calcs

0.0000

0.0003

Tax Effect of Unusual Items

-173.5436

-940.8600

-28,652.4800

12/31/2020 - 10/27/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

QSI Quantum-Si incorporated

0.6330

-4.22%

CERS Cerus Corporation

1.6800

+0.60%

NNOX Nano-X Imaging Ltd.

5.69

+0.18%

SENS Senseonics Holdings, Inc.

0.3177

+5.16%

BFLY Butterfly Network, Inc.

3.0500

+15.53%

DXCM DexCom, Inc.

74.88

-1.82%

TMDX TransMedics Group, Inc.

82.92

+2.46%

SINT Sintx Technologies, Inc.

3.2500

+2.20%

LAB Standard BioTools Inc.

1.5100

+0.67%

NUWE Nuwellis, Inc.

1.3400

-0.74%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pacific Biosciences of California, Inc. (PACB)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers